Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 626-634

  Robbie, Linda ^a   Berry, Susan ^a   Moir, Elaine ^a   Booth, Nuala A ^a   Culligan, Dominic ^b   Tighe, Jane ^b   Watson, Henry ^b   King, Derek ^b   Bennett, Bruce ^a,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Cytokine; Insulin growth factor 1; Interleukin 6; Myeloma

Indexed keywords

GLYCOPROTEIN GP 130; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; SOMATOMEDIN C; STAT3 PROTEIN;

ARTICLE; BONE MATRIX; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MULTIPLE MYELOMA; PHOSPHOPROTEINS; PRECIPITIN TESTS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STIMULATION, CHEMICAL; TRANS-ACTIVATORS;

EID: 0034531866     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02364.x     Document Type: Article

References (35)

1. Secretion of insulin-like growth factor I and insulin-like growth factor- binding proteins by murine bone marrow stromal cells
2. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1
3. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb
4. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma - A new prognostic strategy
5. Mechanisms of bone lesions in multiple myeloma
6. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells
7. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6
8. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons
9. Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae
10. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
11. Insulin-like growth factor binding proteins and their role in controlling IGF actions
12. Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction
13. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis
14. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
15. Insulin-like growth factor-1-mediated protection from neuronal apoptosis is linked to phosphorylation of the pro-apoptotic protein BAD but not to inhibition of cytochrome c translocation in rat cerebellar neurons
16. Agonist anti-gp130 antibodies are myeloma cell survival and proliferation factors
17. Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor
18. Multiple myeloma: Increasing evidence for a multistep transformation process
19. Interleukin-6 prevents dexamethasone-induced myeloma cell death
20. A role for insulin-like growth factor in the regulation of IL-6- responsive human myeloma cell line growth
21. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression
22. Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma
23. Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells
24. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
25. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor
26. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor
27. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
28. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
29. Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells
30. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
31. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis
32. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6
33. The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
34. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma
35. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130